ProKidney Reports Fourth Quarter Financial Results and
WINSTON-SALEM, N.C., March 28, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage...
Stay updated with breaking news from Interventional Procedures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WINSTON-SALEM, N.C., March 28, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage...
WINSTON-SALEM, N.C., March 28, 2023 -- ProKidney Corp. , a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease , today announced financial results for the... | March 28, 2023
To treat all neurological conditions such as stroke/paralysis, Parkinson’s etc.
tmrFebruary 9, 2021 AR Increases Flexibility in Interventional Procedures for Treatment of Aortic Aneurysms Augmented Reality (AR) is revolutionizing the medical imaging lens market. AR is expected to play a pivotal role in challenging applications in the field of image-guided therapy. For instance, leading U.S. multinational technology company Microsoft is using its AR technology in HoloLens 2 holographic computing platform, along with Philips Azurion-a next-gen image-guided therapy platform to address challenges faced by clinicians in interventional procedures. The AR involved image-guide...